LA JOLLA PHARMACEUTICAL CO Restricted Stock or Unit Expense
LA JOLLA PHARMACEUTICAL CO reported Restricted Stock or Unit Expense of $7.84 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2015-03-16
- LA JOLLA PHARMACEUTICAL CO restricted stock or unit expense for fiscal 2014 was $7.84M, a 70.03% increase from fiscal 2013.
- LA JOLLA PHARMACEUTICAL CO restricted stock or unit expense for fiscal 2013 was $4.61M, a 378.32% increase from fiscal 2012.
- LA JOLLA PHARMACEUTICAL CO restricted stock or unit expense for fiscal 2012 was $964.00K.
| Period end | Restricted Stock or Unit Expense 12 month |
|---|---|
| 2014-12-31 | $7.84M 10-K · filed 2015-03-16 |
| 2013-12-31 | $4.61M 10-K · filed 2015-03-16 |
| 2012-12-31 | $964.00K 10-K · filed 2014-03-31 |